Eyestem announces completion of phase one of its RPE Cell Therapy
The trial evaluates the safety and efficacy of Eyecyte-RPE in patients with geographic atrophy secondary to dry age-related…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Eyestem
Eyestem partners with RetinAI
Leveraging RetinAI’s Discovery platform and AI tools will enable Eyestem to advance in its mission to revolutionise treatment for…
Eyestem announces US operations with appointment of Ravi Achar as Head
Also engaged Stradling Yocca Carlson & Rauth as its US law firm
Eyestem raises Series A round led by three pharma majors
The investment will enable Eyestem to progress a treatment for dry age-related macular degeneration to the clinic
Eyestem raises funds from global investors in Switzerland, South Africa
The investment will boost Eyestem's efforts to find treatment for dry age-related macular degeneration, leading cause of incurable…